Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia

Objective: To assess the frequency of HPV-DNA detection, human papillomavirus (HPV) seropositivity, presence of cervical lesions, and its relationship with certain socio-demographic factors in women from Girardot, Colombia from 2006 to 2007. Methods: Nine hundred fifty-three women attending their re...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26786
Acceso en línea:
https://doi.org/10.1097/OLQ.0b013e318195762c
https://repository.urosario.edu.co/handle/10336/26786
Palabra clave:
Papilloma virus infections complications
Seroepidemiologic studies
Uterine cervical neoplasms / epidemiology
Female
Rights
License
Abierto (Texto Completo)
id EDOCUR2_04d1f0b7f65b6f489fafda8b42655814
oai_identifier_str oai:repository.urosario.edu.co:10336/26786
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling a63bfae2-3e79-4b18-b806-3c69bb3fabc3-1aa2fd24c-0eb4-4d73-8a15-c2b3025f602d-1c67d367e-96c2-4566-8a39-374ead1a65f6-167db2a8c-efa7-44a9-a45b-daf72b8f0b09-1dd3af730-1a89-42fc-a5de-64665dc12a41-15e48b055-035f-44d8-9867-a21686777f9d-1796530656002020-08-19T14:40:14Z2020-08-19T14:40:14Z2009-05Objective: To assess the frequency of HPV-DNA detection, human papillomavirus (HPV) seropositivity, presence of cervical lesions, and its relationship with certain socio-demographic factors in women from Girardot, Colombia from 2006 to 2007. Methods: Nine hundred fifty-three women attending their regular Pap smear control voluntarily provided cervical cells and blood samples for HPV-DNA analysis and ELISA detection of anti-L1 peptides and virus-like particles (VLPs) antibodies after answering a questionnaire regarding sexual behaviors, number of births, smoking habits, and socio-demographic background. Results: Twenty-six of the 953 women being examined (2.73%) presented cervical cell abnormalities. A frequency of 36.62% (95% CI: 33.52%–39.7%) HPV seropositivity was detected with peptide 18301, 35.36% (95% CI: 32.3%–38.4%) with 18283, and 32.95% (95% CI: 29.9%–36%) with 18294, whereas VLPs detected a 43% seropositivity (95% CI: 39.8%– 46.2%). Antibody frequency found with all peptides was significantly higher in women having cervical abnormalities (atypical squamous cells of undetermined significance and high-grade squamous intraephitelial lesions) compared with those having normal cytologies. Peptide 18283 reported a significantly higher seropositivity (35.71%) in women 44 years old, whereas peptides 18301 and 18294 evidenced a significantly lower seropositivity in those who had never given birth. HR-HPV-DNA was detected in 157 (20.50%) of 766 cervical samples amplifying positively for the -globin housekeeping gene. Conclusion: Peptides 18283, 18294, and 18301 were more specific and more sensitive than VLPs for detecting women with HR-HPV-DNA positive cervical lesions. Therefore, they could be useful in the design of a serological test for detecting HR-HPV-infected women having cervical lesions at a risk of progressing to cervical cancer.application/pdfhttps://doi.org/10.1097/OLQ.0b013e318195762cISSN: 0148-5717EISSN: 1537-4521https://repository.urosario.edu.co/handle/10336/26786engAmerican Sexually Transmitted Diseases Association296No. 5290Sexually Transmitted Diseases, Journal of the American Venereal Disease AssociationVol. 35Sexually Transmitted Diseases, Journal of the American Venereal Disease Association, ISSN: 0148-5717;EISSN: 1537-4521, Vol.35, No.5 (May 2009); pp. 290-296https://journals.lww.com/stdjournal/Fulltext/2009/05000/Prevalence_of_HPV_DNA_and_Anti_HPV_Antibodies_in.5.aspxAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Sexually Transmitted Diseases, Journal of the American Venereal Disease Associationinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPapilloma virus infections complicationsSeroepidemiologic studiesUterine cervical neoplasms / epidemiologyFemalePrevalence of HPV-DNA and anti-HPV antibodies in women from girardot, ColombiaPrevalencia de VPH-ADN y anticuerpos anti-VPH en mujeres de girardot, ColombiaarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Leon, SandraSánchez, RicardoCamargo, MilenaMejia, AdrianoUrquiza, MauricioPatarroyo, Manuel EPatarroyo, Manuel A.10336/26786oai:repository.urosario.edu.co:10336/267862021-06-03 00:49:59.657https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
dc.title.TranslatedTitle.spa.fl_str_mv Prevalencia de VPH-ADN y anticuerpos anti-VPH en mujeres de girardot, Colombia
title Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
spellingShingle Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
Papilloma virus infections complications
Seroepidemiologic studies
Uterine cervical neoplasms / epidemiology
Female
title_short Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
title_full Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
title_fullStr Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
title_full_unstemmed Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
title_sort Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
dc.subject.keyword.spa.fl_str_mv Papilloma virus infections complications
Seroepidemiologic studies
Uterine cervical neoplasms / epidemiology
Female
topic Papilloma virus infections complications
Seroepidemiologic studies
Uterine cervical neoplasms / epidemiology
Female
description Objective: To assess the frequency of HPV-DNA detection, human papillomavirus (HPV) seropositivity, presence of cervical lesions, and its relationship with certain socio-demographic factors in women from Girardot, Colombia from 2006 to 2007. Methods: Nine hundred fifty-three women attending their regular Pap smear control voluntarily provided cervical cells and blood samples for HPV-DNA analysis and ELISA detection of anti-L1 peptides and virus-like particles (VLPs) antibodies after answering a questionnaire regarding sexual behaviors, number of births, smoking habits, and socio-demographic background. Results: Twenty-six of the 953 women being examined (2.73%) presented cervical cell abnormalities. A frequency of 36.62% (95% CI: 33.52%–39.7%) HPV seropositivity was detected with peptide 18301, 35.36% (95% CI: 32.3%–38.4%) with 18283, and 32.95% (95% CI: 29.9%–36%) with 18294, whereas VLPs detected a 43% seropositivity (95% CI: 39.8%– 46.2%). Antibody frequency found with all peptides was significantly higher in women having cervical abnormalities (atypical squamous cells of undetermined significance and high-grade squamous intraephitelial lesions) compared with those having normal cytologies. Peptide 18283 reported a significantly higher seropositivity (35.71%) in women 44 years old, whereas peptides 18301 and 18294 evidenced a significantly lower seropositivity in those who had never given birth. HR-HPV-DNA was detected in 157 (20.50%) of 766 cervical samples amplifying positively for the -globin housekeeping gene. Conclusion: Peptides 18283, 18294, and 18301 were more specific and more sensitive than VLPs for detecting women with HR-HPV-DNA positive cervical lesions. Therefore, they could be useful in the design of a serological test for detecting HR-HPV-infected women having cervical lesions at a risk of progressing to cervical cancer.
publishDate 2009
dc.date.created.spa.fl_str_mv 2009-05
dc.date.accessioned.none.fl_str_mv 2020-08-19T14:40:14Z
dc.date.available.none.fl_str_mv 2020-08-19T14:40:14Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1097/OLQ.0b013e318195762c
dc.identifier.issn.none.fl_str_mv ISSN: 0148-5717
EISSN: 1537-4521
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/26786
url https://doi.org/10.1097/OLQ.0b013e318195762c
https://repository.urosario.edu.co/handle/10336/26786
identifier_str_mv ISSN: 0148-5717
EISSN: 1537-4521
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 296
dc.relation.citationIssue.none.fl_str_mv No. 5
dc.relation.citationStartPage.none.fl_str_mv 290
dc.relation.citationTitle.none.fl_str_mv Sexually Transmitted Diseases, Journal of the American Venereal Disease Association
dc.relation.citationVolume.none.fl_str_mv Vol. 35
dc.relation.ispartof.spa.fl_str_mv Sexually Transmitted Diseases, Journal of the American Venereal Disease Association, ISSN: 0148-5717;EISSN: 1537-4521, Vol.35, No.5 (May 2009); pp. 290-296
dc.relation.uri.spa.fl_str_mv https://journals.lww.com/stdjournal/Fulltext/2009/05000/Prevalence_of_HPV_DNA_and_Anti_HPV_Antibodies_in.5.aspx
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv American Sexually Transmitted Diseases Association
dc.source.spa.fl_str_mv Sexually Transmitted Diseases, Journal of the American Venereal Disease Association
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390795184570368